MoonLake Immunotherapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$36,007,260 over the previous period. Total operating expenses were $54,123,096.
Profit Margin
| 2020 | 0 | -90.83K | |
|---|---|---|---|
| 2021 | 0 | -53.64M | |
| 2022 | 0 | -64.50M | |
| 2023 | 0 | -36.00M |
MLTX Income Statement (2020 – 2023)
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
Revenue | ||||
Revenue | 0 | 0 | 0 | 0 |
Cost of revenue | 13.15K | 12.35K | 4.97K | 0 |
Gross profit | -13.15K | -12.35K | -4.97K | 0 |
Operating exp. | ||||
Research and development | 31.80M | 42.04M | 35.52M | 0 |
Selling and marketing | 0 | 0 | 18.02M | 0 |
Total operating expenses | 54.12M | 65.06M | 53.57M | 105.75K |
Operating income | -54.12M | -65.06M | -53.57M | -105.76K |
Other income (expenses), net | 10.13M | 591.73K | -61.85K | 14.92K |
Income before tax | -43.98M | -64.46M | -53.63M | -90.83K |
Income tax expense | 94.38K | 36.36K | 4.75K | -206.29K |
Net income | -36.00M | -64.50M | -53.64M | -90.83K |
Earnings per share | ||||
Basic EPS | -0.73 | -2.2 | -6.84 | -0.00 |
Diluted EPS | -0.73 | -2.2 | -6.84 | -0.00 |
| Data source | Data source | Data source | Data source |